Precision Biosciences (DTIL) Long-Term Debt Issuances (2019 - 2024)
Precision Biosciences (DTIL) has disclosed Long-Term Debt Issuances for 4 consecutive years, with -$20000.0 as the latest value for Q4 2024.
- On a quarterly basis, Long-Term Debt Issuances changed N/A to -$20000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$185000.0, a N/A change, with the full-year FY2024 number at $22.5 million, changed N/A from a year prior.
- Long-Term Debt Issuances was -$20000.0 for Q4 2024 at Precision Biosciences, down from -$5000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of -$5000.0 in Q3 2021 to a low of -$160000.0 in Q3 2022.
- A 3-year average of -$47500.0 and a median of -$12500.0 in 2021 define the central range for Long-Term Debt Issuances.
- Biggest YoY gain for Long-Term Debt Issuances was 3100.0% in 2022; the steepest drop was 3100.0% in 2022.
- Precision Biosciences' Long-Term Debt Issuances stood at -$5000.0 in 2021, then changed by 0.0% to -$5000.0 in 2022, then tumbled by 300.0% to -$20000.0 in 2024.
- Per Business Quant, the three most recent readings for DTIL's Long-Term Debt Issuances are -$20000.0 (Q4 2024), -$5000.0 (Q4 2022), and -$160000.0 (Q3 2022).